Clinical Trial Update: Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)

View source ↗

Summary

A registry study in Taiwan is evaluating Abrocitinib for atopic dermatitis, focusing on real-world treatment patterns and outcomes (ATTRACT Registry). The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Cibinqo (abrocitinib)

Snippet

Sponsor: Pfizer | Conditions: Dermatitis, Atopic, Dermatitis | Status: RECRUITING